nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—Microtubule Inhibition—Docetaxel—head and neck cancer	0.314	1	CiPCiCtD
Cabazitaxel—Docetaxel—head and neck cancer	0.294	1	CrCtD
Cabazitaxel—Paclitaxel—Docetaxel—head and neck cancer	0.17	1	CrCrCtD
Cabazitaxel—TUBB2A—Vinblastine—head and neck cancer	0.0118	0.0607	CbGbCtD
Cabazitaxel—TUBB6—Vinblastine—head and neck cancer	0.0118	0.0607	CbGbCtD
Cabazitaxel—TUBB8—Vinblastine—head and neck cancer	0.0118	0.0607	CbGbCtD
Cabazitaxel—TUBB3—Vinblastine—head and neck cancer	0.0118	0.0607	CbGbCtD
Cabazitaxel—TUBB4A—Vinblastine—head and neck cancer	0.0118	0.0607	CbGbCtD
Cabazitaxel—TUBB2B—Vinblastine—head and neck cancer	0.0118	0.0607	CbGbCtD
Cabazitaxel—TUBB1—Vinblastine—head and neck cancer	0.00983	0.0508	CbGbCtD
Cabazitaxel—TUBB4B—Vinblastine—head and neck cancer	0.00983	0.0508	CbGbCtD
Cabazitaxel—TUBB—Vinblastine—head and neck cancer	0.00983	0.0508	CbGbCtD
Cabazitaxel—TUBB8—Docetaxel—head and neck cancer	0.00969	0.05	CbGbCtD
Cabazitaxel—TUBB2B—Docetaxel—head and neck cancer	0.00969	0.05	CbGbCtD
Cabazitaxel—TUBB2A—Docetaxel—head and neck cancer	0.00969	0.05	CbGbCtD
Cabazitaxel—TUBB4A—Docetaxel—head and neck cancer	0.00969	0.05	CbGbCtD
Cabazitaxel—TUBB3—Docetaxel—head and neck cancer	0.00969	0.05	CbGbCtD
Cabazitaxel—TUBB6—Docetaxel—head and neck cancer	0.00969	0.05	CbGbCtD
Cabazitaxel—TUBB—Docetaxel—head and neck cancer	0.00811	0.0419	CbGbCtD
Cabazitaxel—TUBB4B—Docetaxel—head and neck cancer	0.00811	0.0419	CbGbCtD
Cabazitaxel—TUBB1—Docetaxel—head and neck cancer	0.00811	0.0419	CbGbCtD
Cabazitaxel—SLCO1B3—Docetaxel—head and neck cancer	0.00346	0.0179	CbGbCtD
Cabazitaxel—ABCG2—Fluorouracil—head and neck cancer	0.0021	0.0108	CbGbCtD
Cabazitaxel—ABCG2—Docetaxel—head and neck cancer	0.0016	0.00826	CbGbCtD
Cabazitaxel—Neutropenic enterocolitis—Docetaxel—head and neck cancer	0.00134	0.0692	CcSEcCtD
Cabazitaxel—Ureteric obstruction—Hydroxyurea—head and neck cancer	0.00113	0.0584	CcSEcCtD
Cabazitaxel—CYP2C8—Fluorouracil—head and neck cancer	0.00112	0.00576	CbGbCtD
Cabazitaxel—CYP3A5—Docetaxel—head and neck cancer	0.000887	0.00458	CbGbCtD
Cabazitaxel—Neutropenic colitis—Docetaxel—head and neck cancer	0.000836	0.0432	CcSEcCtD
Cabazitaxel—Neutropenic sepsis—Fluorouracil—head and neck cancer	0.00077	0.0398	CcSEcCtD
Cabazitaxel—ABCB1—Vinblastine—head and neck cancer	0.0007	0.00361	CbGbCtD
Cabazitaxel—ABCB1—Docetaxel—head and neck cancer	0.000577	0.00298	CbGbCtD
Cabazitaxel—Neutropenic sepsis—Docetaxel—head and neck cancer	0.000556	0.0287	CcSEcCtD
Cabazitaxel—Septic shock—Fluorouracil—head and neck cancer	0.000442	0.0229	CcSEcCtD
Cabazitaxel—Docetaxel—BCL2—head and neck cancer	0.000427	0.377	CrCbGaD
Cabazitaxel—Paclitaxel—BCL2—head and neck cancer	0.000427	0.377	CrCbGaD
Cabazitaxel—CYP3A4—Vinblastine—head and neck cancer	0.000419	0.00217	CbGbCtD
Cabazitaxel—Enterocolitis—Docetaxel—head and neck cancer	0.000347	0.018	CcSEcCtD
Cabazitaxel—CYP3A4—Docetaxel—head and neck cancer	0.000346	0.00178	CbGbCtD
Cabazitaxel—Mucosal inflammation—Hydroxyurea—head and neck cancer	0.000335	0.0173	CcSEcCtD
Cabazitaxel—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.000308	0.0159	CcSEcCtD
Cabazitaxel—Ileus—Vinblastine—head and neck cancer	0.000287	0.0149	CcSEcCtD
Cabazitaxel—Docetaxel—EGFR—head and neck cancer	0.000279	0.247	CrCbGaD
Cabazitaxel—TUBB—hair follicle—head and neck cancer	0.000243	0.0379	CbGeAlD
Cabazitaxel—Rectal haemorrhage—Vinblastine—head and neck cancer	0.000225	0.0116	CcSEcCtD
Cabazitaxel—Cellulitis—Vinblastine—head and neck cancer	0.000224	0.0116	CcSEcCtD
Cabazitaxel—Febrile neutropenia—Fluorouracil—head and neck cancer	0.000222	0.0115	CcSEcCtD
Cabazitaxel—TUBB3—connective tissue—head and neck cancer	0.00021	0.0328	CbGeAlD
Cabazitaxel—TUBB4B—hair follicle—head and neck cancer	0.000207	0.0324	CbGeAlD
Cabazitaxel—TUBB8—head—head and neck cancer	0.000181	0.0283	CbGeAlD
Cabazitaxel—TUBA4A—parotid gland—head and neck cancer	0.000181	0.0283	CbGeAlD
Cabazitaxel—Mucosal inflammation—Docetaxel—head and neck cancer	0.000174	0.009	CcSEcCtD
Cabazitaxel—TUBA4A—saliva-secreting gland—head and neck cancer	0.000174	0.0271	CbGeAlD
Cabazitaxel—Haemorrhoids—Docetaxel—head and neck cancer	0.000164	0.00847	CcSEcCtD
Cabazitaxel—Febrile neutropenia—Docetaxel—head and neck cancer	0.00016	0.00828	CcSEcCtD
Cabazitaxel—TUBA4A—connective tissue—head and neck cancer	0.000159	0.0249	CbGeAlD
Cabazitaxel—Deep vein thrombosis—Docetaxel—head and neck cancer	0.000158	0.00819	CcSEcCtD
Cabazitaxel—TUBB3—lymphoid tissue—head and neck cancer	0.000154	0.024	CbGeAlD
Cabazitaxel—TUBA4A—epithelium—head and neck cancer	0.000151	0.0236	CbGeAlD
Cabazitaxel—Cellulitis—Fluorouracil—head and neck cancer	0.000147	0.00759	CcSEcCtD
Cabazitaxel—Renal failure acute—Hydroxyurea—head and neck cancer	0.000146	0.00754	CcSEcCtD
Cabazitaxel—Lacrimation increased—Fluorouracil—head and neck cancer	0.000145	0.00749	CcSEcCtD
Cabazitaxel—Intestinal obstruction—Docetaxel—head and neck cancer	0.000141	0.00731	CcSEcCtD
Cabazitaxel—TUBB2B—parotid gland—head and neck cancer	0.00014	0.0219	CbGeAlD
Cabazitaxel—Ileus—Docetaxel—head and neck cancer	0.000136	0.00704	CcSEcCtD
Cabazitaxel—TUBB2B—saliva-secreting gland—head and neck cancer	0.000134	0.021	CbGeAlD
Cabazitaxel—TUBA4A—trachea—head and neck cancer	0.000134	0.0209	CbGeAlD
Cabazitaxel—TUBB—parotid gland—head and neck cancer	0.000133	0.0207	CbGeAlD
Cabazitaxel—TUBB2A—parotid gland—head and neck cancer	0.000132	0.0206	CbGeAlD
Cabazitaxel—TUBB6—parotid gland—head and neck cancer	0.00013	0.0203	CbGeAlD
Cabazitaxel—TUBB4A—connective tissue—head and neck cancer	0.000128	0.0199	CbGeAlD
Cabazitaxel—TUBB—saliva-secreting gland—head and neck cancer	0.000127	0.0199	CbGeAlD
Cabazitaxel—TUBB2A—saliva-secreting gland—head and neck cancer	0.000127	0.0197	CbGeAlD
Cabazitaxel—TUBB6—saliva-secreting gland—head and neck cancer	0.000125	0.0195	CbGeAlD
Cabazitaxel—TUBB3—head—head and neck cancer	0.000124	0.0193	CbGeAlD
Cabazitaxel—TUBB2B—connective tissue—head and neck cancer	0.000124	0.0193	CbGeAlD
Cabazitaxel—Breast disorder—Hydroxyurea—head and neck cancer	0.000122	0.00629	CcSEcCtD
Cabazitaxel—TUBB1—head—head and neck cancer	0.000121	0.0189	CbGeAlD
Cabazitaxel—TUBA4A—lymphoid tissue—head and neck cancer	0.000117	0.0182	CbGeAlD
Cabazitaxel—TUBB2A—connective tissue—head and neck cancer	0.000116	0.0181	CbGeAlD
Cabazitaxel—Sepsis—Fluorouracil—head and neck cancer	0.000116	0.00599	CcSEcCtD
Cabazitaxel—TUBB4B—parotid gland—head and neck cancer	0.000113	0.0177	CbGeAlD
Cabazitaxel—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000112	0.00577	CcSEcCtD
Cabazitaxel—TUBB6—epithelium—head and neck cancer	0.000109	0.017	CbGeAlD
Cabazitaxel—Neutropenia—Hydroxyurea—head and neck cancer	0.000109	0.00563	CcSEcCtD
Cabazitaxel—Dysuria—Hydroxyurea—head and neck cancer	0.000109	0.00563	CcSEcCtD
Cabazitaxel—TUBB4B—saliva-secreting gland—head and neck cancer	0.000108	0.0169	CbGeAlD
Cabazitaxel—Oropharyngeal pain—Docetaxel—head and neck cancer	0.000106	0.00548	CcSEcCtD
Cabazitaxel—TUBA4A—thyroid gland—head and neck cancer	0.000106	0.0165	CbGeAlD
Cabazitaxel—Lacrimation increased—Docetaxel—head and neck cancer	0.000105	0.00541	CcSEcCtD
Cabazitaxel—Infestation—Hydroxyurea—head and neck cancer	0.000104	0.00537	CcSEcCtD
Cabazitaxel—Infestation NOS—Hydroxyurea—head and neck cancer	0.000104	0.00537	CcSEcCtD
Cabazitaxel—TUBB2B—trachea—head and neck cancer	0.000104	0.0162	CbGeAlD
Cabazitaxel—Blood bilirubin increased—Docetaxel—head and neck cancer	0.000102	0.00527	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000102	0.00526	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Vinblastine—head and neck cancer	0.000102	0.00526	CcSEcCtD
Cabazitaxel—TUBB4B—connective tissue—head and neck cancer	9.97e-05	0.0156	CbGeAlD
Cabazitaxel—Cardiac failure—Fluorouracil—head and neck cancer	9.93e-05	0.00514	CcSEcCtD
Cabazitaxel—Lethargy—Fluorouracil—head and neck cancer	9.89e-05	0.00511	CcSEcCtD
Cabazitaxel—TUBB—trachea—head and neck cancer	9.81e-05	0.0153	CbGeAlD
Cabazitaxel—TUBB2A—trachea—head and neck cancer	9.76e-05	0.0152	CbGeAlD
Cabazitaxel—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	9.7e-05	0.00501	CcSEcCtD
Cabazitaxel—TUBB6—trachea—head and neck cancer	9.63e-05	0.015	CbGeAlD
Cabazitaxel—TUBA4A—head—head and neck cancer	9.4e-05	0.0147	CbGeAlD
Cabazitaxel—TUBB4A—lymphoid tissue—head and neck cancer	9.34e-05	0.0146	CbGeAlD
Cabazitaxel—Colitis—Docetaxel—head and neck cancer	9.26e-05	0.00478	CcSEcCtD
Cabazitaxel—Cardiac arrest—Fluorouracil—head and neck cancer	9.22e-05	0.00477	CcSEcCtD
Cabazitaxel—Candida infection—Docetaxel—head and neck cancer	9.2e-05	0.00476	CcSEcCtD
Cabazitaxel—Alopecia—Vinblastine—head and neck cancer	9.03e-05	0.00467	CcSEcCtD
Cabazitaxel—Dry skin—Fluorouracil—head and neck cancer	8.89e-05	0.00459	CcSEcCtD
Cabazitaxel—TUBB4A—thyroid gland—head and neck cancer	8.49e-05	0.0132	CbGeAlD
Cabazitaxel—Angiopathy—Hydroxyurea—head and neck cancer	8.45e-05	0.00437	CcSEcCtD
Cabazitaxel—TUBB6—lymphoid tissue—head and neck cancer	8.38e-05	0.0131	CbGeAlD
Cabazitaxel—TUBB4B—trachea—head and neck cancer	8.37e-05	0.0131	CbGeAlD
Cabazitaxel—Sepsis—Docetaxel—head and neck cancer	8.37e-05	0.00432	CcSEcCtD
Cabazitaxel—Chills—Hydroxyurea—head and neck cancer	8.36e-05	0.00432	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Vinblastine—head and neck cancer	8.25e-05	0.00427	CcSEcCtD
Cabazitaxel—Alopecia—Hydroxyurea—head and neck cancer	8.23e-05	0.00426	CcSEcCtD
Cabazitaxel—Anaemia—Vinblastine—head and neck cancer	8.22e-05	0.00425	CcSEcCtD
Cabazitaxel—TUBB2B—thyroid gland—head and neck cancer	8.2e-05	0.0128	CbGeAlD
Cabazitaxel—Erythema—Hydroxyurea—head and neck cancer	8.11e-05	0.00419	CcSEcCtD
Cabazitaxel—Malaise—Vinblastine—head and neck cancer	8.02e-05	0.00415	CcSEcCtD
Cabazitaxel—Vertigo—Vinblastine—head and neck cancer	7.99e-05	0.00413	CcSEcCtD
Cabazitaxel—Leukopenia—Vinblastine—head and neck cancer	7.96e-05	0.00412	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Fluorouracil—head and neck cancer	7.79e-05	0.00403	CcSEcCtD
Cabazitaxel—TUBB—thyroid gland—head and neck cancer	7.76e-05	0.0121	CbGeAlD
Cabazitaxel—TUBB2A—thyroid gland—head and neck cancer	7.72e-05	0.0121	CbGeAlD
Cabazitaxel—Hypertension—Vinblastine—head and neck cancer	7.68e-05	0.00397	CcSEcCtD
Cabazitaxel—TUBB6—thyroid gland—head and neck cancer	7.62e-05	0.0119	CbGeAlD
Cabazitaxel—TUBB4A—head—head and neck cancer	7.53e-05	0.0118	CbGeAlD
Cabazitaxel—Ill-defined disorder—Hydroxyurea—head and neck cancer	7.53e-05	0.00389	CcSEcCtD
Cabazitaxel—Pneumonia—Fluorouracil—head and neck cancer	7.51e-05	0.00388	CcSEcCtD
Cabazitaxel—Anaemia—Hydroxyurea—head and neck cancer	7.5e-05	0.00388	CcSEcCtD
Cabazitaxel—Discomfort—Vinblastine—head and neck cancer	7.48e-05	0.00387	CcSEcCtD
Cabazitaxel—Hot flush—Docetaxel—head and neck cancer	7.48e-05	0.00387	CcSEcCtD
Cabazitaxel—Infestation NOS—Fluorouracil—head and neck cancer	7.47e-05	0.00386	CcSEcCtD
Cabazitaxel—Infestation—Fluorouracil—head and neck cancer	7.47e-05	0.00386	CcSEcCtD
Cabazitaxel—Menopausal symptoms—Docetaxel—head and neck cancer	7.42e-05	0.00383	CcSEcCtD
Cabazitaxel—Atrial fibrillation—Docetaxel—head and neck cancer	7.38e-05	0.00382	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Fluorouracil—head and neck cancer	7.32e-05	0.00379	CcSEcCtD
Cabazitaxel—Malaise—Hydroxyurea—head and neck cancer	7.32e-05	0.00378	CcSEcCtD
Cabazitaxel—TUBB4B—lymphoid tissue—head and neck cancer	7.29e-05	0.0114	CbGeAlD
Cabazitaxel—TUBB2B—head—head and neck cancer	7.28e-05	0.0114	CbGeAlD
Cabazitaxel—Urinary tract infection—Fluorouracil—head and neck cancer	7.26e-05	0.00375	CcSEcCtD
Cabazitaxel—Conjunctivitis—Fluorouracil—head and neck cancer	7.26e-05	0.00375	CcSEcCtD
Cabazitaxel—Leukopenia—Hydroxyurea—head and neck cancer	7.26e-05	0.00375	CcSEcCtD
Cabazitaxel—Cardiac failure—Docetaxel—head and neck cancer	7.17e-05	0.00371	CcSEcCtD
Cabazitaxel—Lethargy—Docetaxel—head and neck cancer	7.14e-05	0.00369	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Vinblastine—head and neck cancer	7.11e-05	0.00367	CcSEcCtD
Cabazitaxel—Pain in extremity—Docetaxel—head and neck cancer	7e-05	0.00362	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	7e-05	0.00362	CcSEcCtD
Cabazitaxel—Anorexia—Vinblastine—head and neck cancer	6.92e-05	0.00358	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	6.86e-05	0.00355	CcSEcCtD
Cabazitaxel—TUBB2A—head—head and neck cancer	6.85e-05	0.0107	CbGeAlD
Cabazitaxel—Discomfort—Hydroxyurea—head and neck cancer	6.82e-05	0.00353	CcSEcCtD
Cabazitaxel—TUBB6—head—head and neck cancer	6.76e-05	0.0105	CbGeAlD
Cabazitaxel—ABCG2—parotid gland—head and neck cancer	6.68e-05	0.0104	CbGeAlD
Cabazitaxel—Hypoaesthesia—Fluorouracil—head and neck cancer	6.67e-05	0.00345	CcSEcCtD
Cabazitaxel—Oedema—Hydroxyurea—head and neck cancer	6.62e-05	0.00342	CcSEcCtD
Cabazitaxel—TUBB4B—thyroid gland—head and neck cancer	6.62e-05	0.0103	CbGeAlD
Cabazitaxel—TUBA4A—lymph node—head and neck cancer	6.58e-05	0.0103	CbGeAlD
Cabazitaxel—Infection—Hydroxyurea—head and neck cancer	6.58e-05	0.0034	CcSEcCtD
Cabazitaxel—Paraesthesia—Vinblastine—head and neck cancer	6.52e-05	0.00337	CcSEcCtD
Cabazitaxel—Dehydration—Docetaxel—head and neck cancer	6.51e-05	0.00336	CcSEcCtD
Cabazitaxel—Nervous system disorder—Hydroxyurea—head and neck cancer	6.49e-05	0.00336	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Hydroxyurea—head and neck cancer	6.48e-05	0.00335	CcSEcCtD
Cabazitaxel—Skin disorder—Hydroxyurea—head and neck cancer	6.43e-05	0.00332	CcSEcCtD
Cabazitaxel—Dry skin—Docetaxel—head and neck cancer	6.41e-05	0.00332	CcSEcCtD
Cabazitaxel—ABCG2—saliva-secreting gland—head and neck cancer	6.4e-05	0.00999	CbGeAlD
Cabazitaxel—Abdominal pain upper—Docetaxel—head and neck cancer	6.39e-05	0.0033	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Docetaxel—head and neck cancer	6.39e-05	0.0033	CcSEcCtD
Cabazitaxel—Breast disorder—Docetaxel—head and neck cancer	6.32e-05	0.00327	CcSEcCtD
Cabazitaxel—Anorexia—Hydroxyurea—head and neck cancer	6.31e-05	0.00326	CcSEcCtD
Cabazitaxel—Decreased appetite—Vinblastine—head and neck cancer	6.31e-05	0.00326	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	6.3e-05	0.00326	CcSEcCtD
Cabazitaxel—Constipation—Vinblastine—head and neck cancer	6.21e-05	0.00321	CcSEcCtD
Cabazitaxel—Pain—Vinblastine—head and neck cancer	6.21e-05	0.00321	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Docetaxel—head and neck cancer	6.17e-05	0.00319	CcSEcCtD
Cabazitaxel—Arrhythmia—Fluorouracil—head and neck cancer	5.99e-05	0.0031	CcSEcCtD
Cabazitaxel—Feeling abnormal—Vinblastine—head and neck cancer	5.98e-05	0.00309	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Vinblastine—head and neck cancer	5.94e-05	0.00307	CcSEcCtD
Cabazitaxel—Alopecia—Fluorouracil—head and neck cancer	5.93e-05	0.00306	CcSEcCtD
Cabazitaxel—Dyspnoea—Hydroxyurea—head and neck cancer	5.9e-05	0.00305	CcSEcCtD
Cabazitaxel—TUBB4B—head—head and neck cancer	5.87e-05	0.00917	CbGeAlD
Cabazitaxel—Erythema—Fluorouracil—head and neck cancer	5.84e-05	0.00302	CcSEcCtD
Cabazitaxel—Dyspepsia—Hydroxyurea—head and neck cancer	5.83e-05	0.00301	CcSEcCtD
Cabazitaxel—Decreased appetite—Hydroxyurea—head and neck cancer	5.75e-05	0.00297	CcSEcCtD
Cabazitaxel—Abdominal pain—Vinblastine—head and neck cancer	5.74e-05	0.00297	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	5.72e-05	0.00295	CcSEcCtD
Cabazitaxel—Fatigue—Hydroxyurea—head and neck cancer	5.71e-05	0.00295	CcSEcCtD
Cabazitaxel—Pain—Hydroxyurea—head and neck cancer	5.66e-05	0.00293	CcSEcCtD
Cabazitaxel—Constipation—Hydroxyurea—head and neck cancer	5.66e-05	0.00293	CcSEcCtD
Cabazitaxel—Neutropenia—Docetaxel—head and neck cancer	5.66e-05	0.00292	CcSEcCtD
Cabazitaxel—Weight decreased—Docetaxel—head and neck cancer	5.47e-05	0.00283	CcSEcCtD
Cabazitaxel—Feeling abnormal—Hydroxyurea—head and neck cancer	5.46e-05	0.00282	CcSEcCtD
Cabazitaxel—Pneumonia—Docetaxel—head and neck cancer	5.42e-05	0.0028	CcSEcCtD
Cabazitaxel—Anaemia—Fluorouracil—head and neck cancer	5.4e-05	0.00279	CcSEcCtD
Cabazitaxel—Infestation—Docetaxel—head and neck cancer	5.39e-05	0.00279	CcSEcCtD
Cabazitaxel—Infestation NOS—Docetaxel—head and neck cancer	5.39e-05	0.00279	CcSEcCtD
Cabazitaxel—Hypersensitivity—Vinblastine—head and neck cancer	5.35e-05	0.00276	CcSEcCtD
Cabazitaxel—Renal failure—Docetaxel—head and neck cancer	5.3e-05	0.00274	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Docetaxel—head and neck cancer	5.29e-05	0.00273	CcSEcCtD
Cabazitaxel—TUBB4A—lymph node—head and neck cancer	5.27e-05	0.00823	CbGeAlD
Cabazitaxel—Conjunctivitis—Docetaxel—head and neck cancer	5.24e-05	0.00271	CcSEcCtD
Cabazitaxel—Body temperature increased—Hydroxyurea—head and neck cancer	5.23e-05	0.00271	CcSEcCtD
Cabazitaxel—Leukopenia—Fluorouracil—head and neck cancer	5.23e-05	0.0027	CcSEcCtD
Cabazitaxel—Asthenia—Vinblastine—head and neck cancer	5.21e-05	0.00269	CcSEcCtD
Cabazitaxel—TUBB2B—lymph node—head and neck cancer	5.1e-05	0.00795	CbGeAlD
Cabazitaxel—Myalgia—Fluorouracil—head and neck cancer	4.97e-05	0.00257	CcSEcCtD
Cabazitaxel—Chest pain—Fluorouracil—head and neck cancer	4.97e-05	0.00257	CcSEcCtD
Cabazitaxel—Diarrhoea—Vinblastine—head and neck cancer	4.97e-05	0.00257	CcSEcCtD
Cabazitaxel—Discomfort—Fluorouracil—head and neck cancer	4.91e-05	0.00254	CcSEcCtD
Cabazitaxel—Hypersensitivity—Hydroxyurea—head and neck cancer	4.88e-05	0.00252	CcSEcCtD
Cabazitaxel—TUBB—lymph node—head and neck cancer	4.82e-05	0.00753	CbGeAlD
Cabazitaxel—Hypoaesthesia—Docetaxel—head and neck cancer	4.82e-05	0.00249	CcSEcCtD
Cabazitaxel—Confusional state—Fluorouracil—head and neck cancer	4.8e-05	0.00248	CcSEcCtD
Cabazitaxel—Dizziness—Vinblastine—head and neck cancer	4.8e-05	0.00248	CcSEcCtD
Cabazitaxel—TUBB2A—lymph node—head and neck cancer	4.8e-05	0.00749	CbGeAlD
Cabazitaxel—Urinary tract disorder—Docetaxel—head and neck cancer	4.78e-05	0.00247	CcSEcCtD
Cabazitaxel—Oedema peripheral—Docetaxel—head and neck cancer	4.77e-05	0.00247	CcSEcCtD
Cabazitaxel—Oedema—Fluorouracil—head and neck cancer	4.77e-05	0.00246	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Docetaxel—head and neck cancer	4.76e-05	0.00246	CcSEcCtD
Cabazitaxel—Asthenia—Hydroxyurea—head and neck cancer	4.75e-05	0.00246	CcSEcCtD
Cabazitaxel—Urethral disorder—Docetaxel—head and neck cancer	4.75e-05	0.00245	CcSEcCtD
Cabazitaxel—Infection—Fluorouracil—head and neck cancer	4.73e-05	0.00245	CcSEcCtD
Cabazitaxel—TUBB6—lymph node—head and neck cancer	4.73e-05	0.00738	CbGeAlD
Cabazitaxel—Nervous system disorder—Fluorouracil—head and neck cancer	4.67e-05	0.00242	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Fluorouracil—head and neck cancer	4.67e-05	0.00241	CcSEcCtD
Cabazitaxel—Tachycardia—Fluorouracil—head and neck cancer	4.65e-05	0.0024	CcSEcCtD
Cabazitaxel—Vomiting—Vinblastine—head and neck cancer	4.62e-05	0.00239	CcSEcCtD
Cabazitaxel—Headache—Vinblastine—head and neck cancer	4.55e-05	0.00235	CcSEcCtD
Cabazitaxel—Anorexia—Fluorouracil—head and neck cancer	4.54e-05	0.00235	CcSEcCtD
Cabazitaxel—Diarrhoea—Hydroxyurea—head and neck cancer	4.53e-05	0.00234	CcSEcCtD
Cabazitaxel—Eye disorder—Docetaxel—head and neck cancer	4.52e-05	0.00234	CcSEcCtD
Cabazitaxel—Cardiac disorder—Docetaxel—head and neck cancer	4.49e-05	0.00232	CcSEcCtD
Cabazitaxel—Flushing—Docetaxel—head and neck cancer	4.49e-05	0.00232	CcSEcCtD
Cabazitaxel—Hypotension—Fluorouracil—head and neck cancer	4.45e-05	0.0023	CcSEcCtD
Cabazitaxel—Angiopathy—Docetaxel—head and neck cancer	4.39e-05	0.00227	CcSEcCtD
Cabazitaxel—Dizziness—Hydroxyurea—head and neck cancer	4.38e-05	0.00226	CcSEcCtD
Cabazitaxel—Immune system disorder—Docetaxel—head and neck cancer	4.37e-05	0.00226	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Docetaxel—head and neck cancer	4.36e-05	0.00226	CcSEcCtD
Cabazitaxel—Chills—Docetaxel—head and neck cancer	4.34e-05	0.00225	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	4.34e-05	0.00224	CcSEcCtD
Cabazitaxel—Arrhythmia—Docetaxel—head and neck cancer	4.32e-05	0.00224	CcSEcCtD
Cabazitaxel—Nausea—Vinblastine—head and neck cancer	4.31e-05	0.00223	CcSEcCtD
Cabazitaxel—Paraesthesia—Fluorouracil—head and neck cancer	4.28e-05	0.00221	CcSEcCtD
Cabazitaxel—Alopecia—Docetaxel—head and neck cancer	4.28e-05	0.00221	CcSEcCtD
Cabazitaxel—Dyspnoea—Fluorouracil—head and neck cancer	4.25e-05	0.0022	CcSEcCtD
Cabazitaxel—Mental disorder—Docetaxel—head and neck cancer	4.24e-05	0.00219	CcSEcCtD
Cabazitaxel—Erythema—Docetaxel—head and neck cancer	4.21e-05	0.00218	CcSEcCtD
Cabazitaxel—Malnutrition—Docetaxel—head and neck cancer	4.21e-05	0.00218	CcSEcCtD
Cabazitaxel—Vomiting—Hydroxyurea—head and neck cancer	4.21e-05	0.00218	CcSEcCtD
Cabazitaxel—Dyspepsia—Fluorouracil—head and neck cancer	4.19e-05	0.00217	CcSEcCtD
Cabazitaxel—Headache—Hydroxyurea—head and neck cancer	4.15e-05	0.00214	CcSEcCtD
Cabazitaxel—Decreased appetite—Fluorouracil—head and neck cancer	4.14e-05	0.00214	CcSEcCtD
Cabazitaxel—Dysgeusia—Docetaxel—head and neck cancer	4.13e-05	0.00213	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Fluorouracil—head and neck cancer	4.11e-05	0.00213	CcSEcCtD
Cabazitaxel—TUBB4B—lymph node—head and neck cancer	4.11e-05	0.00642	CbGeAlD
Cabazitaxel—Back pain—Docetaxel—head and neck cancer	4.08e-05	0.00211	CcSEcCtD
Cabazitaxel—Pain—Fluorouracil—head and neck cancer	4.07e-05	0.00211	CcSEcCtD
Cabazitaxel—Muscle spasms—Docetaxel—head and neck cancer	4.05e-05	0.00209	CcSEcCtD
Cabazitaxel—Nausea—Hydroxyurea—head and neck cancer	3.93e-05	0.00203	CcSEcCtD
Cabazitaxel—Feeling abnormal—Fluorouracil—head and neck cancer	3.93e-05	0.00203	CcSEcCtD
Cabazitaxel—ABCG2—thyroid gland—head and neck cancer	3.9e-05	0.00609	CbGeAlD
Cabazitaxel—Anaemia—Docetaxel—head and neck cancer	3.9e-05	0.00201	CcSEcCtD
Cabazitaxel—Leukopenia—Docetaxel—head and neck cancer	3.77e-05	0.00195	CcSEcCtD
Cabazitaxel—Body temperature increased—Fluorouracil—head and neck cancer	3.77e-05	0.00195	CcSEcCtD
Cabazitaxel—Cough—Docetaxel—head and neck cancer	3.68e-05	0.0019	CcSEcCtD
Cabazitaxel—Hypertension—Docetaxel—head and neck cancer	3.64e-05	0.00188	CcSEcCtD
Cabazitaxel—Arthralgia—Docetaxel—head and neck cancer	3.59e-05	0.00185	CcSEcCtD
Cabazitaxel—Chest pain—Docetaxel—head and neck cancer	3.59e-05	0.00185	CcSEcCtD
Cabazitaxel—Myalgia—Docetaxel—head and neck cancer	3.59e-05	0.00185	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	3.56e-05	0.00184	CcSEcCtD
Cabazitaxel—Hypersensitivity—Fluorouracil—head and neck cancer	3.51e-05	0.00181	CcSEcCtD
Cabazitaxel—Dry mouth—Docetaxel—head and neck cancer	3.51e-05	0.00181	CcSEcCtD
Cabazitaxel—Confusional state—Docetaxel—head and neck cancer	3.47e-05	0.00179	CcSEcCtD
Cabazitaxel—Oedema—Docetaxel—head and neck cancer	3.44e-05	0.00178	CcSEcCtD
Cabazitaxel—Infection—Docetaxel—head and neck cancer	3.42e-05	0.00177	CcSEcCtD
Cabazitaxel—Nervous system disorder—Docetaxel—head and neck cancer	3.37e-05	0.00174	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Docetaxel—head and neck cancer	3.37e-05	0.00174	CcSEcCtD
Cabazitaxel—Tachycardia—Docetaxel—head and neck cancer	3.36e-05	0.00174	CcSEcCtD
Cabazitaxel—Skin disorder—Docetaxel—head and neck cancer	3.34e-05	0.00173	CcSEcCtD
Cabazitaxel—Anorexia—Docetaxel—head and neck cancer	3.28e-05	0.00169	CcSEcCtD
Cabazitaxel—Diarrhoea—Fluorouracil—head and neck cancer	3.26e-05	0.00169	CcSEcCtD
Cabazitaxel—Hypotension—Docetaxel—head and neck cancer	3.21e-05	0.00166	CcSEcCtD
Cabazitaxel—Dizziness—Fluorouracil—head and neck cancer	3.15e-05	0.00163	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Docetaxel—head and neck cancer	3.13e-05	0.00162	CcSEcCtD
Cabazitaxel—Paraesthesia—Docetaxel—head and neck cancer	3.09e-05	0.0016	CcSEcCtD
Cabazitaxel—Dyspnoea—Docetaxel—head and neck cancer	3.07e-05	0.00158	CcSEcCtD
Cabazitaxel—Vomiting—Fluorouracil—head and neck cancer	3.03e-05	0.00157	CcSEcCtD
Cabazitaxel—Dyspepsia—Docetaxel—head and neck cancer	3.03e-05	0.00156	CcSEcCtD
Cabazitaxel—Decreased appetite—Docetaxel—head and neck cancer	2.99e-05	0.00155	CcSEcCtD
Cabazitaxel—Headache—Fluorouracil—head and neck cancer	2.99e-05	0.00154	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Docetaxel—head and neck cancer	2.97e-05	0.00153	CcSEcCtD
Cabazitaxel—Fatigue—Docetaxel—head and neck cancer	2.97e-05	0.00153	CcSEcCtD
Cabazitaxel—Pain—Docetaxel—head and neck cancer	2.94e-05	0.00152	CcSEcCtD
Cabazitaxel—Constipation—Docetaxel—head and neck cancer	2.94e-05	0.00152	CcSEcCtD
Cabazitaxel—Feeling abnormal—Docetaxel—head and neck cancer	2.83e-05	0.00147	CcSEcCtD
Cabazitaxel—Nausea—Fluorouracil—head and neck cancer	2.83e-05	0.00146	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Docetaxel—head and neck cancer	2.81e-05	0.00145	CcSEcCtD
Cabazitaxel—ABCB1—epithelium—head and neck cancer	2.75e-05	0.0043	CbGeAlD
Cabazitaxel—Abdominal pain—Docetaxel—head and neck cancer	2.72e-05	0.00141	CcSEcCtD
Cabazitaxel—Body temperature increased—Docetaxel—head and neck cancer	2.72e-05	0.00141	CcSEcCtD
Cabazitaxel—Hypersensitivity—Docetaxel—head and neck cancer	2.53e-05	0.00131	CcSEcCtD
Cabazitaxel—Asthenia—Docetaxel—head and neck cancer	2.47e-05	0.00128	CcSEcCtD
Cabazitaxel—ABCB1—trachea—head and neck cancer	2.43e-05	0.0038	CbGeAlD
Cabazitaxel—ABCG2—lymph node—head and neck cancer	2.43e-05	0.00379	CbGeAlD
Cabazitaxel—Diarrhoea—Docetaxel—head and neck cancer	2.35e-05	0.00122	CcSEcCtD
Cabazitaxel—TUBB4B—Pathogenic Escherichia coli infection—CDH1—head and neck cancer	2.31e-05	0.00857	CbGpPWpGaD
Cabazitaxel—Dizziness—Docetaxel—head and neck cancer	2.27e-05	0.00118	CcSEcCtD
Cabazitaxel—Vomiting—Docetaxel—head and neck cancer	2.19e-05	0.00113	CcSEcCtD
Cabazitaxel—Headache—Docetaxel—head and neck cancer	2.15e-05	0.00111	CcSEcCtD
Cabazitaxel—ABCB1—lymphoid tissue—head and neck cancer	2.12e-05	0.00331	CbGeAlD
Cabazitaxel—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—CASP8—head and neck cancer	2.11e-05	0.00782	CbGpPWpGaD
Cabazitaxel—Nausea—Docetaxel—head and neck cancer	2.04e-05	0.00106	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—CCNA1—head and neck cancer	1.97e-05	0.00729	CbGpPWpGaD
Cabazitaxel—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—CASP8—head and neck cancer	1.93e-05	0.00715	CbGpPWpGaD
Cabazitaxel—ABCB1—thyroid gland—head and neck cancer	1.93e-05	0.003	CbGeAlD
Cabazitaxel—TUBB2A—Signaling events mediated by HDAC Class III—TP53—head and neck cancer	1.86e-05	0.0069	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—CCNA1—head and neck cancer	1.76e-05	0.00652	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet degranulation—VEGFA—head and neck cancer	1.73e-05	0.0064	CbGpPWpGaD
Cabazitaxel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	1.72e-05	0.00639	CbGpPWpGaD
Cabazitaxel—ABCB1—head—head and neck cancer	1.71e-05	0.00267	CbGeAlD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.69e-05	0.00627	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.69e-05	0.00627	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—CCNA1—head and neck cancer	1.67e-05	0.0062	CbGpPWpGaD
Cabazitaxel—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	1.64e-05	0.0061	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.63e-05	0.00606	CbGpPWpGaD
Cabazitaxel—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	1.61e-05	0.00598	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.58e-05	0.00587	CbGpPWpGaD
Cabazitaxel—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	1.55e-05	0.00574	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.55e-05	0.00574	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CCNA1—head and neck cancer	1.5e-05	0.00555	CbGpPWpGaD
Cabazitaxel—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	1.47e-05	0.00544	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—RAD51—head and neck cancer	1.41e-05	0.00524	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.39e-05	0.00515	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CCNA1—head and neck cancer	1.39e-05	0.00514	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—GRP—head and neck cancer	1.37e-05	0.00509	CbGpPWpGaD
Cabazitaxel—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	1.35e-05	0.005	CbGpPWpGaD
Cabazitaxel—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	1.3e-05	0.00481	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.27e-05	0.00471	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CCNA1—head and neck cancer	1.27e-05	0.0047	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-2-alpha transcription factor network—VEGFA—head and neck cancer	1.24e-05	0.0046	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CCNA1—head and neck cancer	1.24e-05	0.0046	CbGpPWpGaD
Cabazitaxel—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	1.22e-05	0.00452	CbGpPWpGaD
Cabazitaxel—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	1.21e-05	0.00447	CbGpPWpGaD
Cabazitaxel—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	1.2e-05	0.00447	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—RAD51—head and neck cancer	1.2e-05	0.00446	CbGpPWpGaD
Cabazitaxel—ABCB1—lymph node—head and neck cancer	1.2e-05	0.00187	CbGeAlD
Cabazitaxel—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	1.19e-05	0.00441	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—GRP—head and neck cancer	1.18e-05	0.00436	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—GRP—head and neck cancer	1.18e-05	0.00436	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.15e-05	0.00426	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—GRP—head and neck cancer	1.14e-05	0.00421	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CCNA1—head and neck cancer	1.13e-05	0.0042	CbGpPWpGaD
Cabazitaxel—CYP3A5—Biological oxidations—NAT2—head and neck cancer	1.11e-05	0.00411	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—GRP—head and neck cancer	1.1e-05	0.00408	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	1.09e-05	0.00405	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—GRP—head and neck cancer	1.08e-05	0.00399	CbGpPWpGaD
Cabazitaxel—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	1.04e-05	0.00387	CbGpPWpGaD
Cabazitaxel—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	1.03e-05	0.00382	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—UROD—head and neck cancer	1.02e-05	0.00379	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—RAD51—head and neck cancer	9.96e-06	0.00369	CbGpPWpGaD
Cabazitaxel—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.76e-06	0.00362	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—GRP—head and neck cancer	9.66e-06	0.00358	CbGpPWpGaD
Cabazitaxel—ABCG2—Fluoropyrimidine Activity—TP53—head and neck cancer	9.59e-06	0.00356	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—NAT2—head and neck cancer	9.59e-06	0.00356	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—TYMS—head and neck cancer	9.49e-06	0.00352	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	9.46e-06	0.00351	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—RAD51—head and neck cancer	9.11e-06	0.00338	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—IL2—head and neck cancer	9.01e-06	0.00334	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—GRP—head and neck cancer	8.83e-06	0.00328	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TYMS—head and neck cancer	8.49e-06	0.00315	CbGpPWpGaD
Cabazitaxel—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	8.45e-06	0.00314	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—TYMS—head and neck cancer	8.07e-06	0.00299	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.94e-06	0.00294	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	7.71e-06	0.00286	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	7.66e-06	0.00284	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	7.29e-06	0.00271	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	7.24e-06	0.00269	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TYMS—head and neck cancer	7.22e-06	0.00268	CbGpPWpGaD
Cabazitaxel—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	7.17e-06	0.00266	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	7.14e-06	0.00265	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	7.03e-06	0.00261	CbGpPWpGaD
Cabazitaxel—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	6.92e-06	0.00257	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	6.89e-06	0.00256	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—UROD—head and neck cancer	6.87e-06	0.00255	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—TYMS—head and neck cancer	6.69e-06	0.00248	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	6.39e-06	0.00237	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—UROD—head and neck cancer	6.36e-06	0.00236	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—TYMS—head and neck cancer	6.12e-06	0.00227	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	5.98e-06	0.00222	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TYMS—head and neck cancer	5.98e-06	0.00222	CbGpPWpGaD
Cabazitaxel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	5.6e-06	0.00208	CbGpPWpGaD
Cabazitaxel—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	5.52e-06	0.00205	CbGpPWpGaD
Cabazitaxel—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	5.47e-06	0.00203	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TYMS—head and neck cancer	5.47e-06	0.00203	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	5.39e-06	0.002	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.33e-06	0.00198	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—CASP8—head and neck cancer	5.32e-06	0.00197	CbGpPWpGaD
Cabazitaxel—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	5.18e-06	0.00192	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—NAT2—head and neck cancer	5.15e-06	0.00191	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	5.11e-06	0.0019	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	5.08e-06	0.00188	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	4.89e-06	0.00181	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—CCND1—head and neck cancer	4.78e-06	0.00177	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	4.74e-06	0.00176	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	4.67e-06	0.00173	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	4.65e-06	0.00173	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—IL2—head and neck cancer	4.64e-06	0.00172	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—UROD—head and neck cancer	4.56e-06	0.00169	CbGpPWpGaD
Cabazitaxel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	4.54e-06	0.00168	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.51e-06	0.00167	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	4.49e-06	0.00167	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.47e-06	0.00166	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	4.43e-06	0.00164	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—CCND1—head and neck cancer	4.27e-06	0.00158	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—NAT2—head and neck cancer	4.25e-06	0.00158	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—CCND1—head and neck cancer	4.06e-06	0.00151	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL2—head and neck cancer	4.02e-06	0.00149	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—UROD—head and neck cancer	3.95e-06	0.00147	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—VEGFA—head and neck cancer	3.95e-06	0.00146	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	3.94e-06	0.00146	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	3.94e-06	0.00146	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	3.86e-06	0.00143	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	3.84e-06	0.00142	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	3.75e-06	0.00139	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—MAPK3—head and neck cancer	3.73e-06	0.00138	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—DPYD—head and neck cancer	3.72e-06	0.00138	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CCND1—head and neck cancer	3.63e-06	0.00135	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—MAPK1—head and neck cancer	3.55e-06	0.00132	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—YAP1—head and neck cancer	3.53e-06	0.00131	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—MAPK3—head and neck cancer	3.52e-06	0.00131	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—UROD—head and neck cancer	3.44e-06	0.00128	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	3.41e-06	0.00127	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CCND1—head and neck cancer	3.37e-06	0.00125	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—MAPK1—head and neck cancer	3.35e-06	0.00124	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—MAPK3—head and neck cancer	3.35e-06	0.00124	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—MAPK1—head and neck cancer	3.19e-06	0.00118	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—PIK3CA—head and neck cancer	3.08e-06	0.00114	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—head and neck cancer	3.08e-06	0.00114	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.06e-06	0.00114	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.03e-06	0.00112	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CCND1—head and neck cancer	3.01e-06	0.00112	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3e-06	0.00111	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—MAPK3—head and neck cancer	3e-06	0.00111	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TP53—head and neck cancer	2.98e-06	0.00111	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NAT2—head and neck cancer	2.85e-06	0.00106	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—HRAS—head and neck cancer	2.85e-06	0.00106	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—MAPK1—head and neck cancer	2.85e-06	0.00106	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TP53—head and neck cancer	2.81e-06	0.00104	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	2.78e-06	0.00103	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CCND1—head and neck cancer	2.75e-06	0.00102	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.66e-06	0.000985	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NAT2—head and neck cancer	2.64e-06	0.00098	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	2.64e-06	0.00098	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	2.62e-06	0.000973	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	2.54e-06	0.000943	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—MAPK3—head and neck cancer	2.54e-06	0.000942	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—AKT1—head and neck cancer	2.52e-06	0.000934	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	2.52e-06	0.000933	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	2.51e-06	0.00093	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—DPYD—head and neck cancer	2.5e-06	0.000928	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MAPK3—head and neck cancer	2.48e-06	0.000921	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—MAPK1—head and neck cancer	2.42e-06	0.000896	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	2.41e-06	0.000894	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—head and neck cancer	2.39e-06	0.000888	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	2.38e-06	0.000882	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—YAP1—head and neck cancer	2.37e-06	0.000881	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MAPK1—head and neck cancer	2.36e-06	0.000876	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—DPYD—head and neck cancer	2.32e-06	0.00086	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.32e-06	0.000859	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MAPK3—head and neck cancer	2.27e-06	0.000842	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	2.25e-06	0.000835	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—YAP1—head and neck cancer	2.2e-06	0.000816	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MAPK1—head and neck cancer	2.16e-06	0.000801	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	2.14e-06	0.000794	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—TYMS—head and neck cancer	2.12e-06	0.000787	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—UROD—head and neck cancer	2.12e-06	0.000786	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GSTM1—head and neck cancer	2.1e-06	0.000778	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GPX1—head and neck cancer	2.01e-06	0.000745	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CYP1A1—head and neck cancer	1.99e-06	0.000738	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—head and neck cancer	1.98e-06	0.000736	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.93e-06	0.000717	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NAT2—head and neck cancer	1.89e-06	0.000702	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.87e-06	0.000692	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—head and neck cancer	1.81e-06	0.000673	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.78e-06	0.000662	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.74e-06	0.000646	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.72e-06	0.00064	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.69e-06	0.000625	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—DPYD—head and neck cancer	1.66e-06	0.000616	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NAT2—head and neck cancer	1.64e-06	0.000608	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.63e-06	0.000606	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.59e-06	0.000591	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—YAP1—head and neck cancer	1.58e-06	0.000584	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.56e-06	0.000577	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.52e-06	0.000563	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.52e-06	0.000562	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—DPYD—head and neck cancer	1.44e-06	0.000533	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NAT2—head and neck cancer	1.43e-06	0.00053	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—TYMS—head and neck cancer	1.43e-06	0.000529	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTM1—head and neck cancer	1.41e-06	0.000523	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—YAP1—head and neck cancer	1.36e-06	0.000506	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GPX1—head and neck cancer	1.35e-06	0.000501	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP1A1—head and neck cancer	1.34e-06	0.000496	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—TYMS—head and neck cancer	1.32e-06	0.00049	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.32e-06	0.000488	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTM1—head and neck cancer	1.31e-06	0.000484	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.27e-06	0.000472	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—DPYD—head and neck cancer	1.25e-06	0.000465	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GPX1—head and neck cancer	1.25e-06	0.000464	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP1A1—head and neck cancer	1.24e-06	0.000459	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—YAP1—head and neck cancer	1.19e-06	0.000441	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTGS2—head and neck cancer	1.18e-06	0.000439	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.1e-06	0.000407	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.08e-06	0.000399	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTEN—head and neck cancer	1.03e-06	0.000383	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.03e-06	0.00038	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—TYMS—head and neck cancer	9.46e-07	0.000351	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTM1—head and neck cancer	9.35e-07	0.000347	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GPX1—head and neck cancer	8.96e-07	0.000332	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.94e-07	0.000332	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP1A1—head and neck cancer	8.86e-07	0.000329	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NAT2—head and neck cancer	8.8e-07	0.000327	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—TYMS—head and neck cancer	8.19e-07	0.000304	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTM1—head and neck cancer	8.1e-07	0.0003	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTGS2—head and neck cancer	7.95e-07	0.000295	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GPX1—head and neck cancer	7.76e-07	0.000288	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—DPYD—head and neck cancer	7.72e-07	0.000286	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP1A1—head and neck cancer	7.68e-07	0.000285	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTGS2—head and neck cancer	7.36e-07	0.000273	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—YAP1—head and neck cancer	7.32e-07	0.000272	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CA—head and neck cancer	7.28e-07	0.00027	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TYMS—head and neck cancer	7.14e-07	0.000265	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTM1—head and neck cancer	7.06e-07	0.000262	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTEN—head and neck cancer	6.93e-07	0.000257	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GPX1—head and neck cancer	6.76e-07	0.000251	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP1A1—head and neck cancer	6.69e-07	0.000248	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTEN—head and neck cancer	6.42e-07	0.000238	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.31e-07	0.000234	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—AKT1—head and neck cancer	5.94e-07	0.000221	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTGS2—head and neck cancer	5.27e-07	0.000196	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CA—head and neck cancer	4.89e-07	0.000181	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTEN—head and neck cancer	4.6e-07	0.000171	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTGS2—head and neck cancer	4.57e-07	0.000169	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CA—head and neck cancer	4.53e-07	0.000168	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TYMS—head and neck cancer	4.4e-07	0.000163	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.35e-07	0.000161	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GPX1—head and neck cancer	4.16e-07	0.000154	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.12e-07	0.000153	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—AKT1—head and neck cancer	3.99e-07	0.000148	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTEN—head and neck cancer	3.98e-07	0.000148	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTGS2—head and neck cancer	3.98e-07	0.000148	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—AKT1—head and neck cancer	3.7e-07	0.000137	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTEN—head and neck cancer	3.47e-07	0.000129	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CA—head and neck cancer	3.24e-07	0.00012	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CA—head and neck cancer	2.81e-07	0.000104	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—AKT1—head and neck cancer	2.65e-07	9.83e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.45e-07	9.09e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CA—head and neck cancer	2.45e-07	9.08e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKT1—head and neck cancer	2.29e-07	8.51e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTEN—head and neck cancer	2.14e-07	7.93e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKT1—head and neck cancer	2e-07	7.42e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.51e-07	5.59e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKT1—head and neck cancer	1.23e-07	4.57e-05	CbGpPWpGaD
